Background: Non adherence to hydroxyurea in SCD patients becomes a major problem that needs immediate attention by health care providers, using patient counselling which in turn may increase rate of adherence that may contribute in improving their clinical outcomes and reduce hospitalization for pain crisis. Problem statements: Many sickle cell disease patients quit taking their hydroxyurea medication which in turn deteriorates their health status and increase rate of pain crisis. Hypothesis: Dose pharmacists counseling improve (SCD) patient’s adherence to hydroxyurea at king Fahad university hospital. Dose adherence to hydroxyurea can decrease rate of pain crisis. Objectives: To measures impact of pharmacist intervention on patient adhe...
Medication adherence in sickle cell disease (SCD) is associated with important clinical outcomes and...
Background:A decline in hospitalizations and pain episodes among those with sickle cell disease (SCD...
Background: There are about 95,000 Americans living with sickle cell disease. The illness can lead t...
Sickle cell Disease (SCD) is an autosomal recessive disorder that affects 50,000 to 100,000 people i...
While laboratory and clinical benefits of hydroxyurea for patients with sickle cell disease (SCD) ar...
Sickle cell disease is a disabling chronic autosomal recessive blood disease characterized by abnorm...
Thesis (Master's)--University of Washington, 2022Background: Sickle cell disease (SCD) is one of the...
© 2020 Academy of Managed Care Pharmacy (AMCP). All rights reserved. BACKGROUND: Individuals with si...
BACKGROUND:Hydroxyurea prevents disease complications among patients with sickle cell disease (SCD)....
Sickle cell disease (SCD) is an inherited blood disorder that affects about 100,000 people in the U....
OBJECTIVES: Describe rates of adherence for sickle cell disease (SCD) medications, identify patient ...
Abstract Background Sickle cell disease (SCD) patients have impaired domains of health-related quali...
Background Hydroxyurea (HU) is recommended as standard practice for youth with sickl...
Introduction: SCD patients experience declines in health-related quality of life (HRQOL) domains com...
BackgroundSickle Cell Disease (SCD) is a progressive genetic disease that causes organ damage and re...
Medication adherence in sickle cell disease (SCD) is associated with important clinical outcomes and...
Background:A decline in hospitalizations and pain episodes among those with sickle cell disease (SCD...
Background: There are about 95,000 Americans living with sickle cell disease. The illness can lead t...
Sickle cell Disease (SCD) is an autosomal recessive disorder that affects 50,000 to 100,000 people i...
While laboratory and clinical benefits of hydroxyurea for patients with sickle cell disease (SCD) ar...
Sickle cell disease is a disabling chronic autosomal recessive blood disease characterized by abnorm...
Thesis (Master's)--University of Washington, 2022Background: Sickle cell disease (SCD) is one of the...
© 2020 Academy of Managed Care Pharmacy (AMCP). All rights reserved. BACKGROUND: Individuals with si...
BACKGROUND:Hydroxyurea prevents disease complications among patients with sickle cell disease (SCD)....
Sickle cell disease (SCD) is an inherited blood disorder that affects about 100,000 people in the U....
OBJECTIVES: Describe rates of adherence for sickle cell disease (SCD) medications, identify patient ...
Abstract Background Sickle cell disease (SCD) patients have impaired domains of health-related quali...
Background Hydroxyurea (HU) is recommended as standard practice for youth with sickl...
Introduction: SCD patients experience declines in health-related quality of life (HRQOL) domains com...
BackgroundSickle Cell Disease (SCD) is a progressive genetic disease that causes organ damage and re...
Medication adherence in sickle cell disease (SCD) is associated with important clinical outcomes and...
Background:A decline in hospitalizations and pain episodes among those with sickle cell disease (SCD...
Background: There are about 95,000 Americans living with sickle cell disease. The illness can lead t...